Enanta Pharmaceuticals
ENTA
#8021
Rank
ยฃ0.15 B
Marketcap
ยฃ7.41
Share price
0.32%
Change (1 day)
-6.01%
Change (1 year)

Revenue for Enanta Pharmaceuticals (ENTA)

Revenue in 2024 (TTM): ยฃ57.36 Million

According to Enanta Pharmaceuticals 's latest financial reports the company's current revenue (TTM ) is ยฃ57.12 Million. In 2023 the company made a revenue of ยฃ57.78 Million a decrease over the revenue in the year 2022 that were of ยฃ67.85 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Enanta Pharmaceuticals from 2012 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) ยฃ57.36 M-0.73%
2023 ยฃ57.78 M-14.84%
2022 ยฃ67.85 M-1.48%
2021 ยฃ68.88 M-7.63%
2020 ยฃ74.57 M-47.95%
2019 ยฃ0.14 B-23.71%
2018 ยฃ0.18 B94.5%
2017 ยฃ96.56 M137.16%
2016 ยฃ40.71 M-54.23%
2015 ยฃ88.95 M11.38%
2014 ยฃ79.86 M2489.78%
2013 ยฃ3.08 M-92.76%
2012 ยฃ42.58 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ยฃ43.65 B 76,331.35%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ69.61 B 121,767.70%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ8.20 B 14,265.48%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ49.59 B 86,724.62%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ37.65 B 65,818.57%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ39.64 B 69,299.67%๐Ÿ‡จ๐Ÿ‡ญ Switzerland